A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at challenges in diagnosing breast cancer in Tanzania and support that could help improve testing. It includes interviews and group talks with breast cancer survivors, patient advocates, and healthcare staff, plus a review of medical records.
The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- For interviews and group talks: Be a breast cancer survivor, a patient advocate, or a key healthcare worker.
- Healthcare workers may include hospital or lab leaders, doctors who diagnose or treat cancer, lab staff, nurses, and surgeons.
- Healthcare workers must have worked at their hospital or lab for more than 12 months and help manage or provide breast cancer care.
- For interviews and group talks: Be age 18 or older and a permanent resident or citizen of Tanzania.
- You or your legally authorized representative must be willing and able to agree to take part.
- For interviews and group talks: Report that you speak Swahili, English, or both fluently.
- For medical record review: Records must be for people age 18 or older who are permanent residents or citizens of Tanzania and have a breast cancer diagnosis.
Who can't join
- For interviews and group talks: Key participants who are not at their own hospital or institution during data collection cannot take part.
- For medical record review: Records for people younger than 18 are not included.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Participant Inclusion Criteria for interviews and focus group discussions (Aims 1 and 2): * Breast cancer survivor, patient advocate or key healthcare personnel * Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with: * \>12 months of employment at the affiliated institution * Administrative or clinical involvement in the delivery of breast cancer care services. * Age 18 years and above * Permanent residents or citizens of Tanzania * Participant and/or LAR willing and able to consent * Fluent in Swahili and/or English by self-report Participant Exclusion Criteria: * Key stakeholder not residing at their particular institutions during data collection will be excluded. Eligibility criteria for Chart Reviews (Aim 1) Inclusion Criteria for chart review: * Age 18 years and above * Permanent residents or citizens of Tanzania * Received breast cancer diagnosis Exclusion Criteria for chart review: * Participants less than 18 years of age
Study sites (1)
NY
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) · New York, NY 10065Diana Ng, MD · Study contact · 212-639-7209 · NgD2@mskcc.orgMore trials in New York